According to ICRA, Indian pharmaceutical companies are expected to generate revenue growth of 8-10% in FY2025, while growth in the US and Europe would slow
According to Mythri Macherla, Assistant Vice President & Sector Head at ICRA, “the operating profit margin (OPM) for the sample …